Prothena | PRTA - Ebitda

Aktienkurs
10.75
Täglich Wechseln
0.02 0.19%
Monatlich
15.47%
Jährlich
10.82%
Q2 Prognose
10.43




Ebitda Veränderung Datum
Acadia Pharmaceuticals USD 35.76M 447K 2025-09
Agios Pharmaceuticals USD -115.49M 10.3M 2025-09
Akebia Therapeutics USD 14.03M 17.19M 2025-03
ALKERMES USD 100.31M 21.24M 2025-12
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
Amgen USD 5.14B 775M 2025-12
Biogen USD 573.2M 253.7M 2025-12
BioMarin Pharmaceutical USD -24.17M 18.91M 2025-12
Exelixis USD 248.93M 28.02M 2025-09
Immunic USD -22.78M 753K 2024-06
Incyte USD 414.5M 92.42M 2025-12
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
MacroGenics USD 21.95M 55.39M 2025-09
Nektar Therapeutics USD -31.81M 70K 2023-09
Neurocrine Biosciences USD 218.4M 28.3M 2025-12
Prothena USD -39.53M 12.25M 2025-09
Regeneron Pharmaceuticals USD 1.92B 261.9M 2025-09
Ultragenyx Pharmaceutical USD -156.79M 65.44M 2025-09
Vertex Pharmaceuticals USD 1.44B 100.4M 2025-09
Xoma USD 2.52M 7.98M 2024-06